As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for samples received on April 20, at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Babesia is a selective pooled NAT test, required for all blood donations collected by May 2020, in 14 States and the District of Columbia. To help you understand the requirements, CTS will host a Babesia Implementation and Review webinar on March 3, 2020 at 11:00 am CST. If you are interested in attending, please contact your Customer Service Manager for invitation details.
CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinu...
Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA test...
TEMPE, Ariz. (Sept. 8, 2022) — Marion Lanteri, Ph.D., began this week as Creative Testing Solu...
On August 9, 2019, the new CTS Laboratory Information System was successfully implemented in St...
The FDA Guidance ZIKV video for the webinar held on 08/15/18 has been posted in the Wh...
CTS implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The newly...